Assessment of Outcomes after Stopping Tyrosine Kinase Inhibitors among Patients with Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
Ehab Atallah, Charles A. Schiffer, Jerald P. Radich, Kevin P. Weinfurt, Mei Jie Zhang, Javier Pinilla-Ibarz, Vamsi Kota, Richard A. Larson, Joseph O. Moore, Michael J. Mauro, Michael W.N. Deininger, James E. Thompson, Vivian G. Oehler, Martha Wadleigh, Neil P. Shah, Ellen K. Ritchie, Richard T. Silver, Jorge Cortes, Li Lin, Alexis VisotckyArielle Baim, Jill Harrell, Bret Helton, Mary Horowitz, Kathryn E. Flynn
Dive into the research topics of 'Assessment of Outcomes after Stopping Tyrosine Kinase Inhibitors among Patients with Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial'. Together they form a unique fingerprint.